https://doi.org/10.1186/s40360-020-00424-3
T
Takashi Ueda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
1.3K
Citations
19
h-index
36
i10-index
Takashi Ueda is an academic researcher from Hyogo Medical University. The author has contributed to research in topics: Antimicrobial Resistance in Staphylococcus & Antibiotics Pharmacokinetics and Efficacy & Bacterial Identification and Susceptibility Testing. The author has an h-index of 19, co-authored 133 publications.
ORCID: 0000-0002-5176-9050Papers by this author
worksClinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
2020 · BMC Pharmacology and Toxicology · 48 citations
Cardiac rehabilitation in patients with cardiovascular disease leads various hemodynamic parameters obtained using simple non-invasive tests to their appropriate levels
2017 · IJC Heart & Vasculature · 4 citations
https://doi.org/10.1016/j.ijcha.2017.10.001
Masquerading Spleen: A Perplexing Case of Intrahepatic Splenosis Mimicking Hepatocellular Carcinoma
2024 · Cureus · 2 citations
https://doi.org/10.7759/cureus.70145
Judicious ending of isolation based on reverse transcription–polymerase chain reaction (RT-PCR) cycle threshold only for patients with coronavirus disease 2019 (COVID-19) requiring in-hospital therapy for longer than 20 days after symptom onset
2023 · Journal of Infection and Chemotherapy · 1 citations
https://doi.org/10.1016/j.jiac.2023.05.007
Additional file 2 of Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.12629560
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat